SABILA SHAH: Open Payments
NPI 1407413248 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,358 in 176 payments from 29 companies in 2025. Trend: 2023 $5,210 · 2024 $3,858 · 2025 $4,358
Food & beverage: $3,766Travel & lodging: $502Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 58 | $1,049 |
| Abbott Laboratories | 14 | $952 |
| Teva Pharmaceuticals USA, Inc. | 37 | $793 |
| Neurocrine BioSciences, Inc. | 10 | $183 |
| Axsome Therapeutics, Inc. | 7 | $176 |
| LivaNova USA, Inc. | 3 | $159 |
| Amneal Pharmaceuticals LLC | 8 | $139 |
| JAZZ PHARMACEUTICALS INC. | 2 | $121 |
| SK Life Science, Inc. | 4 | $96 |
| Lundbeck LLC | 5 | $96 |
Products named: INFINITY, AUSTEDO XR, UBRELVY, QULIPTA, BOTOX, INGREZZA, VYALEV, VNS THERAPY SENTIVA MODEL 1000 GENERATOR.
Industry payments across NY — which companies pay providers there.
